Page last updated: 2024-10-27

fluoxetine and ACD-MPV

fluoxetine has been researched along with ACD-MPV in 1 studies

Fluoxetine: The first highly specific serotonin uptake inhibitor. It is used as an antidepressant and often has a more acceptable side-effects profile than traditional antidepressants.
fluoxetine : A racemate comprising equimolar amounts of (R)- and (S)-fluoxetine. A selective serotonin reuptake inhibitor (SSRI), it is used (generally as the hydrochloride salt) for the treatment of depression (and the depressive phase of bipolar disorder), bullimia nervosa, and obsessive-compulsive disorder.
N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine : An aromatic ether consisting of 4-trifluoromethylphenol in which the hydrogen of the phenolic hydroxy group is replaced by a 3-(methylamino)-1-phenylpropyl group.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hooper, CW1
Delaney, C1
Streeter, T1
Yarboro, MT1
Poole, S1
Brown, N1
Slaughter, JC1
Cotton, RB1
Reese, J1
Shelton, EL1

Other Studies

1 other study available for fluoxetine and ACD-MPV

ArticleYear
Selective serotonin reuptake inhibitor exposure constricts the mouse ductus arteriosus in utero.
    American journal of physiology. Heart and circulatory physiology, 2016, 09-01, Volume: 311, Issue:3

    Topics: Animals; Aorta; Ductus Arteriosus; Female; Fluoxetine; Immunohistochemistry; Mice; Myography; Persis

2016